Market Overview:
The global cell lysis and disruption market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation applications. In addition, the growing demand for biotechnology and pharmaceutical products is also contributing to the growth of this market. The mammalian cells segment is expected to dominate the global cell lysis and disruption market in terms of revenue in 2018.
Product Definition:
Cell Lysis is the breaking of cells, and Disruption is the destruction of their membranes. They are both important techniques in biochemistry and molecular biology, as they allow for the extraction of cellular contents (proteins, nucleic acids) for further study.
Mammalian cells:
Mammalian cells are used for the production of monoclonal antibodies, cell-based vaccines, and other products. They are also used as an alternative to Chinese Hamster Ovarian (CHO) cells in research settings. The primary driver for this market is the growing usage of mammalian cell lines in biopharmaceutical R&D activities.
Bacterial cells:
Bacterial cells and it's usage in Cell Lysis & Disruption market is primarily driven by the increasing prevalence of chronic diseases such as cancer, diabetes, arthritis and other autoimmune disorders. The rising geriatric population base coupled with unhealthy lifestyles are also contributing towards the growing prevalence of these chronic diseases. Bacterial cells are used for lysis or disruption depending on its type which is further employed for obtaining crude protein from animal sources or plant sources respectively.
Application Insights:
Protein isolation was the prominent application segment in the global market and accounted for a revenue share of over 40.0% in 2017. The demand is projected to arise from various applications such as biopharmaceuticals, academic research, and clinical diagnostics. In addition, increasing focus on personalized medicines is expected to boost product demand during the forecast period.
The downstream processing segment held a significant share in 2018 owing to rising investments by companies for developing new products that can be used across various industries such as food & beverage and cosmetics among others. For instance, FMC Technologies developed an advanced protein purification process known as ¢â‚¬Å“High Throughput Purification¢â‚¬ (HTP) which enables high purity protein production at lower costs than conventional methods while maintaining similar levels of productivity1).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a substantial number of biotechnology and pharmaceutical companies. Moreover, these companies are continuously engaged in R&D activities for isolation of target cells from various sources, which is anticipated to fuel regional growth over the forecast period.
Asia Pacific region is expected to grow at a lucrative rate over the forecast period owing to increasing investments by government and private entities for development of healthcare infrastructure. This has resulted in an increase in demand for cell lysis & disruption products across this region. In addition, growing medical tourism industry due to low cost associated with treatment at specialized centers is also expected drive regional growth during the forecast period.
Growth Factors:
- Increasing demand for cell-based therapies and regenerative medicines
- Growing prevalence of chronic diseases
- Technological advancements in cell lysis and disruption methods
- Rising funding for research on cell-based therapies
- Growing number of collaborations between pharmaceutical companies and biotechnology firms
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Lysis & Disruption Market Research Report
By Type
Mammalian cells, Bacterial cells, Yeast/Algae/Fungi, Plant cells
By Application
Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation
By Companies
Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Qiagen NV, Becton Dickinson & Company (BD), Danaher Corporation, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Claremont BioSolutions, LLC, Microfluidics International Corporation, Parr Instrument Company, BioVision, Inc., Covaris, Inc., Qsonica LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Cell Lysis & Disruption Market Report Segments:
The global Cell Lysis & Disruption market is segmented on the basis of:
Types
Mammalian cells, Bacterial cells, Yeast/Algae/Fungi, Plant cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Qiagen NV
- Becton Dickinson & Company (BD)
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH
- Claremont BioSolutions, LLC
- Microfluidics International Corporation
- Parr Instrument Company
- BioVision, Inc.
- Covaris, Inc.
- Qsonica LLC
Highlights of The Cell Lysis & Disruption Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mammalian cells
- Bacterial cells
- Yeast/Algae/Fungi
- Plant cells
- By Application:
- Protein Isolation
- Downstream Processing
- Cell Organelle Isolation
- Nucleic Acid Isolation
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Lysis & Disruption Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell lysis is the process of breaking down a cell membrane. Disruption is the result of this process, which can cause damage to the cell.
Some of the key players operating in the cell lysis & disruption market are Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Qiagen NV, Becton Dickinson & Company (BD), Danaher Corporation, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Claremont BioSolutions, LLC, Microfluidics International Corporation, Parr Instrument Company, BioVision, Inc., Covaris, Inc., Qsonica LLC.
The cell lysis & disruption market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Lysis & Disruption Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Lysis & Disruption Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Lysis & Disruption Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Lysis & Disruption Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Lysis & Disruption Market Size & Forecast, 2018-2028
4.5.1 Cell Lysis & Disruption Market Size and Y-o-Y Growth
4.5.2 Cell Lysis & Disruption Market Absolute $ Opportunity
Chapter 5 Global Cell Lysis & Disruption Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell Lysis & Disruption Market Size Forecast by Type
5.2.1 Mammalian cells
5.2.2 Bacterial cells
5.2.3 Yeast/Algae/Fungi
5.2.4 Plant cells
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell Lysis & Disruption Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell Lysis & Disruption Market Size Forecast by Applications
6.2.1 Protein Isolation
6.2.2 Downstream Processing
6.2.3 Cell Organelle Isolation
6.2.4 Nucleic Acid Isolation
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Lysis & Disruption Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Lysis & Disruption Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell Lysis & Disruption Analysis and Forecast
9.1 Introduction
9.2 North America Cell Lysis & Disruption Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell Lysis & Disruption Market Size Forecast by Type
9.6.1 Mammalian cells
9.6.2 Bacterial cells
9.6.3 Yeast/Algae/Fungi
9.6.4 Plant cells
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell Lysis & Disruption Market Size Forecast by Applications
9.10.1 Protein Isolation
9.10.2 Downstream Processing
9.10.3 Cell Organelle Isolation
9.10.4 Nucleic Acid Isolation
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell Lysis & Disruption Analysis and Forecast
10.1 Introduction
10.2 Europe Cell Lysis & Disruption Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell Lysis & Disruption Market Size Forecast by Type
10.6.1 Mammalian cells
10.6.2 Bacterial cells
10.6.3 Yeast/Algae/Fungi
10.6.4 Plant cells
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell Lysis & Disruption Market Size Forecast by Applications
10.10.1 Protein Isolation
10.10.2 Downstream Processing
10.10.3 Cell Organelle Isolation
10.10.4 Nucleic Acid Isolation
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell Lysis & Disruption Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell Lysis & Disruption Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell Lysis & Disruption Market Size Forecast by Type
11.6.1 Mammalian cells
11.6.2 Bacterial cells
11.6.3 Yeast/Algae/Fungi
11.6.4 Plant cells
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell Lysis & Disruption Market Size Forecast by Applications
11.10.1 Protein Isolation
11.10.2 Downstream Processing
11.10.3 Cell Organelle Isolation
11.10.4 Nucleic Acid Isolation
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell Lysis & Disruption Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell Lysis & Disruption Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell Lysis & Disruption Market Size Forecast by Type
12.6.1 Mammalian cells
12.6.2 Bacterial cells
12.6.3 Yeast/Algae/Fungi
12.6.4 Plant cells
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell Lysis & Disruption Market Size Forecast by Applications
12.10.1 Protein Isolation
12.10.2 Downstream Processing
12.10.3 Cell Organelle Isolation
12.10.4 Nucleic Acid Isolation
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell Lysis & Disruption Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell Lysis & Disruption Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell Lysis & Disruption Market Size Forecast by Type
13.6.1 Mammalian cells
13.6.2 Bacterial cells
13.6.3 Yeast/Algae/Fungi
13.6.4 Plant cells
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell Lysis & Disruption Market Size Forecast by Applications
13.10.1 Protein Isolation
13.10.2 Downstream Processing
13.10.3 Cell Organelle Isolation
13.10.4 Nucleic Acid Isolation
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Lysis & Disruption Market: Competitive Dashboard
14.2 Global Cell Lysis & Disruption Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific, Inc.
14.3.2 Merck KGaA
14.3.3 F. Hoffmann-La Roche Ltd
14.3.4 Qiagen NV
14.3.5 Becton Dickinson & Company (BD)
14.3.6 Danaher Corporation
14.3.7 Bio-Rad Laboratories, Inc.
14.3.8 Miltenyi Biotec GmbH
14.3.9 Claremont BioSolutions, LLC
14.3.10 Microfluidics International Corporation
14.3.11 Parr Instrument Company
14.3.12 BioVision, Inc.
14.3.13 Covaris, Inc.
14.3.14 Qsonica LLC
